Brief: Indaptus Therapeutics Announces Completion of First Patient to Receive Multiple Doses of Decoy20, the Company’s Broad-Based, “Pulse-Prime” Immuno-Oncology Therapy for Advanced Solid Tumors
22/05/2024 13:18
May 22 (Reuters) - Indaptus Therapeutics Inc INDP.O :
* INDAPTUS THERAPEUTICS ANNOUNCES COMPLETION OF FIRST
PATIENT TO
RECEIVE MULTIPLE DOSES OF DECOY20, THE COMPANY’S BROAD-BASED,
“PULSE-PRIME” IMMUNO-ONCOLOGY THERAPY FOR ADVANCED SOLID TUMORS
Source text for Eikon: ID:nGNX8Qk5Qb
Further company coverage: INDP.O
((Reuters.Briefs@thomsonreuters.com;))